Related Experiment Video

Updated: Sep 4, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

18F-DCFPyL PET/CT in Men with Prostate Cancer

Katherine A Zukotynski1, Phillip H Kuo1

  • 1From the Departments of Radiology and Medicine, McMaster University, 1200 Main St W, Room 1P11, Hamilton, ON, Canada L8N 3Z5 (K.A.Z.); and Departments of Medical Imaging, Medicine, and Biomedical Engineering, University of Arizona, Tucson, Ariz (P.H.K.).

Radiology
|July 19, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

10.6K
Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
10:02

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

18.4K

Related Experiment Videos

Last Updated: Sep 4, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

10.6K
Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
10:02

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

18.4K

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

5.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.3K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

230
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
230

Articles linked to this work by shared authors, journal, and citation graph.

A Practical Guide to PSMA PET Radiopharmaceuticals for Prostate Cancer Imaging, From the AJR Special Series on Molecular Imaging.

AJR. American journal of roentgenology·2026

Development and Implementation of a Radiation Safety Screening Protocol for a Clinical Study Using Amyloid Positron Emission Tomography Imaging.

Ochsner journal·2026

Integration of PSMA PET into the New Recommendations from Prostate Cancer Working Group 4 for Prostate Cancer Trials.

Journal of nuclear medicine technology·2026

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

ACR Appropriateness Criteria® Evaluation of Cardiac Masses.

Journal of the American College of Radiology : JACR·2026

Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Diagnostically Calibrated AI Image Quality Framework Applied to Prostate Cancer Detection at MRI.

Radiology·2026

68Ga-NK224 PET/CT Reveals Intra- and Intertumoral Heterogeneity of PD-L1 in Non-Small Cell Lung Cancer.

Radiology·2026

Multinational Validation of a Radiography-Based AI Tool for Appendicular Fracture Detection and Corresponding Reader Performance.

Radiology·2026

Call to Action: Accelerating AI-driven Transformation in Medical Imaging and the Broader Health Care System.

Radiology·2026

MRI Metabolic Biomarkers Predict Ischemic Lesion Survival in Hyperacute Stroke: New Insight on Diffusion Reversibility.

Radiology·2026

Contrast-enhanced CT Radiomics for High-Grade Pattern Identification and Prognostic Stratification in Lung Adenocarcinoma with Consolidation-to-Tumor Ratio of 25% or More.

Radiology·2026

AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

American journal of rhinology & allergy·2026

Risk factors for carfilzomib-related cardiovascular adverse events in Chinese patients with multiple myeloma: A real-world retrospective cohort study.

The Journal of international medical research·2026

HSPA8 globally modulates transcriptome profile and PI3K/AKT signaling pathway to facilitate malignant progression phenotypes of triple-negative breast cancer.

Science progress·2026

Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.

American journal of clinical oncology·2026

Prognostic value of inflammation-immunity-nutrition score in cancer patients: a meta-analysis.

Annals of medicine·2026

ASSOCIATION OF SYNOVITIS ACTIVITY MEASURED BY SYNOVIAL TISSUE VOLUME (STV) AND DYNAMIC CONTRAST-ENHANCED (DCE)-MRI IN PATIENTS WITH INFLAMMATORY KNEE OSTEOARTHRITIS.

Osteoarthritis imaging·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us